166 related articles for article (PubMed ID: 20005925)
1. Potential use of melatonergic drugs in analgesia: mechanisms of action.
Srinivasan V; Pandi-Perumal SR; Spence DW; Moscovitch A; Trakht I; Brown GM; Cardinali DP
Brain Res Bull; 2010 Mar; 81(4-5):362-71. PubMed ID: 20005925
[TBL] [Abstract][Full Text] [Related]
2. Melatonin: a hormone that modulates pain.
Ambriz-Tututi M; Rocha-González HI; Cruz SL; Granados-Soto V
Life Sci; 2009 Apr; 84(15-16):489-98. PubMed ID: 19223003
[TBL] [Abstract][Full Text] [Related]
3. Melatonin and its agonists in pain modulation and its clinical application.
Srinivasan V; Zakaria R; Jeet Singh H; Acuna-Castroviejo D
Arch Ital Biol; 2012 Dec; 150(4):274-89. PubMed ID: 23479460
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive properties of the hydroalcoholic extract and the flavonoid rutin obtained from Polygala paniculata L. in mice.
Lapa Fda R; Gadotti VM; Missau FC; Pizzolatti MG; Marques MC; Dafré AL; Farina M; Rodrigues AL; Santos AR
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):306-15. PubMed ID: 19281602
[TBL] [Abstract][Full Text] [Related]
5. Medical implications of melatonin: receptor-mediated and receptor-independent actions.
Reiter RJ; Tan DX; Manchester LC; Pilar Terron M; Flores LJ; Koppisepi S
Adv Med Sci; 2007; 52():11-28. PubMed ID: 18217386
[TBL] [Abstract][Full Text] [Related]
6. Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cells.
Radogna F; Paternoster L; Albertini MC; Cerella C; Accorsi A; Bucchini A; Spadoni G; Diamantini G; Tarzia G; De Nicola M; D'Alessio M; Ghibelli L
J Pineal Res; 2007 Sep; 43(2):154-62. PubMed ID: 17645693
[TBL] [Abstract][Full Text] [Related]
7. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
Rice AS; Farquhar-Smith WP; Nagy I
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
[TBL] [Abstract][Full Text] [Related]
9. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.
Witt-Enderby PA; Radio NM; Doctor JS; Davis VL
J Pineal Res; 2006 Nov; 41(4):297-305. PubMed ID: 17014686
[TBL] [Abstract][Full Text] [Related]
11. Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain.
Liu YY; Yin D; Chen L; Qu WM; Chen CR; Laudon M; Cheng NN; Urade Y; Huang ZL
Psychopharmacology (Berl); 2014 Oct; 231(20):3973-85. PubMed ID: 24700387
[TBL] [Abstract][Full Text] [Related]
12. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
Reiter RJ
Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
[TBL] [Abstract][Full Text] [Related]
13. Evaluation for the interaction between intrathecal melatonin and clonidine or neostigmine on formalin-induced nociception.
Yoon MH; Park HC; Kim WM; Lee HG; Kim YO; Huang LJ
Life Sci; 2008 Dec; 83(25-26):845-50. PubMed ID: 19000700
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
15. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
Björkman R
Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
[TBL] [Abstract][Full Text] [Related]
16. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice.
Li SR; Wang T; Wang R; Dai X; Chen Q; Li RD
Brain Res; 2005 May; 1043(1-2):132-8. PubMed ID: 15862526
[TBL] [Abstract][Full Text] [Related]
17. Melatonin: new places in therapy.
Maharaj DS; Glass BD; Daya S
Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
[TBL] [Abstract][Full Text] [Related]
18. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
19. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
20. Melatonin: Nature's most versatile biological signal?
Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
